Avacta Share Discussion Threads

[the drewster] 23/10/2019 07:33

... but it seems almost certain that Avacta will need more cash again in 2020/2021?

[mikro1] 23/10/2019 07:27

Most small cap shares fall when the market knows they need to raise cash

[escapetohome] 22/10/2019 23:38

Many companies :

(A)make it clear they need to raise cash (b) manage to sign several deals which they would have expected to have increased the share price (c) communicated extensively with the market via RNSs and presentations (d) raise the cash.

And their share price rises as planned.

Avactas falls. WHY.???????

[money multipier] 22/10/2019 22:37

Agree that the price should be multiples higher if the trial is delivered successfully. So, either there is only a small chance of success, which is not what Alastair is suggesting, or the company has failed to sell the story well and the market is sceptical of success. If everything is as rosy as suggested the market cap should have been much higher and investors should have been falling over each other to have a slice of the action.
I hope all is well as I’d like a profit out of this one day.

[mikro1] 22/10/2019 22:05

The drop has been painful for me too. However I can’t fault the company. They have (a) made it clear they needed to raise cash (b) managed to sign several deals which they would have expected to have increased the share price (c) communicated extensively with the market via RNSs and presentations (d) raised the cash. It is the market that has created the low price which has meant a heavy dilution for holders including me. I am buying more as I foresee positive news flow over the next 6 months and if the human trial is delivered successfully and on time, this should be 10x higher in 12 months

[nordic1958] 22/10/2019 15:19

Astra Zeneca approved this ADC dealLet us now move forward and look forward to ahead of schedule phase 1 trials

[chilly0] 22/10/2019 13:51

Yes Tufts collaboration is now vital for the success of the company. Idea worked in mouse model or so we are told. Any improvement from the current administration of this tox drug would be significant. Well not long to wait.

[nordic1958] 22/10/2019 11:52

The ADC tie up is important as ADC is an Astra Zeneca backed company, they sit on the board and AVCT is now on their radar screen.Astra Zeneca is investing heavily in the hottest sector at the moment:ONCOLOGY

[milkmonsta] 22/10/2019 11:42

The in-human trials are going to be the maker or breaker for this company. if it works, they could well be doing deals with upfront payments large enough to not need more fund raising. If it doesn't - well, that will probably be the end.

Fingers crossed, heart in the mouth and squeaky bum times ahead.

[lantanatony] 22/10/2019 11:11

Spot on Drewster.
A very poor show indeed.
Where is the revenue from the on going deals?
It's all so vague at Avacta and I can not see that changing with the present Board.

[nordic1958] 22/10/2019 08:28

Just read latest presentation All facts

[wanobi] 22/10/2019 08:19

cannot argue with a word you've said there Drewster,,, other than to say at least they can raise more cash when they need it and have not gone bust,,,, so people must believe they will get somewhere with their technology and when they do and deals come the share price will rise very fast indeed...... when = IF = when = IF,,,, LOL Cheers Wan :-)

I am a holder who is currently 60% down on this stock :-) YIKES

[the drewster] 22/10/2019 08:10

Good business management raise money, use it wisely to "prove up value" (at value inflection points) and then by doing so, the market capitalisation appreciates, the share price goes up, and fund raising to grow the business is via placings and subscriptions at ever INCREASING prices so that shareholders are rewarded for their investment.

Alastair - please read and take note.

Latest proposal: raise £9m @ 15p/share

Previous raises:
30/07/2018: £11.4m @ 25p
15/07/2015: £22m @ 125p
07/05/2014: £10.1m @ 110p
18/07/2013: £4.7m @ 55p

There are c. 116m shares in issue before this placing, so assuming that (as is invariably the case short term) the shares tend towards the placing price of 15p, we will have a market capitalisation of approx £27m from cumulative cash raising exercises of over £57m since July 2013. Very poor show.

[lantanatony] 21/10/2019 23:46

Is that a question or a statement?
Or just some more hype from Avacta!?

[nordic1958] 21/10/2019 09:28

Phase one trials starting next year Ahead of schedule

[nobbygnome] 19/10/2019 07:53

Not a surprise they came back for more money. When I went to the research day early this year, it was clear a big fund raising was coming. The management hinted they would deliver a few more deals ahead of it to maybe sustain the price but nevertheless I didn't like what I heard and sold most of my holding shortly afterwards. I was completely out a few months later as the price drifted off.

A big worry for me is that they still haven't put an affimer into a human. Until you do there is a finite (but small) risk of a strange immune response or some other reaction. For me it is absolutely amazing they have come this far without taking that major step and shows poor management.

So I am pleased I am out but good luck to the holders. It may yet come good because the technology is good in a number of ways but I have my doubts about the management.

[lantanatony] 18/10/2019 22:09

Well!
Milkmonster, You are a Jonny come lately opportunist or just a fool.
If any of Avacta's investment story's stood up then you may have a case .
Just ask yourself, if there was any guaranteed revenue coming from the LG and other publicise deals do you think Avacta would be raising money at 15 pence ( 0.15 pence in old money)
The Board are living on shareholders money and have been doing so for a long time!
Welcome the Bear pit.

[escapetohome] 18/10/2019 19:07

Yes , the best way is sustainabile fund raising.

Raise money , yes, but sustainably so, making concommitant progress with the raising.

THATS WHAT INVESTORS ARE HERE FOR TO HELP COMPANIES GROW WITH THEIR CAPITAL NEEDS.

[milkmonsta] 18/10/2019 18:50

I just re watched the sharesoc presentation from March 2019 as I seemed to remember someone asking about future fund raising and dilutions going forward.

Alistair was very open about the fact that there could be a number of these before they were able to generate deals with upfront payments large enough to self fund.

As much as i am frustrated by the share price and my investment funds disappearing faster than i am comfortable with - the company has been doing deals - there is interest from other notable companies in collaborations. The things that are going to create the value in this company are still "under development" and may or may not come to fruition.

The company has to keep moving forward little by little and managing it's cash, and developing relationships with more and more interested parties in the process.

They are doing this. High risk this certainly is. High reward this could be. But that time is not soon, and the company does not say otherwise.

[escapetohome] 18/10/2019 16:18

I will not be backing this company again.

[escapetohome] 18/10/2019 16:18

An unsatisfactory performance.

[escapetohome] 18/10/2019 16:17

Alastair Smith, CEO, has agreed to subscribe for 33,334 Subscription Shares at the Issue Price for a total of GBP5,000. His resultant holding will be 679,643 Ordinary Shares representing approximately 0.39 per cent of the Enlarged Share Capital as set out below.

Wow well done Alaistair.

Is this another ‘job’

Ie forward sold all the shares?

I am unhappy avacta with your performance.

[lantanatony] 18/10/2019 14:55

No other CEO would hold onto his job,with this kind of record!?

[nordic1958] 18/10/2019 14:54

Think you chaps should watch the news flowThis fund raise was oversubscribed and the company as stated is in new discussions.Watch the share price